Correlation of serum hepatitis B surface antigen level with response to entecavir in naive patients with chronic hepatitis B
Not Applicable
Completed
- Conditions
- Certain infectious and parasitic diseases
- Registration Number
- KCT0000087
- Lead Sponsor
- Ajou University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 101
Inclusion Criteria
naive patients with chronic hepatitis B who received 0.5mg entecavir once daily more than 12 months from Ajou University Hospital.
Exclusion Criteria
Patients who had hepatocellular carcinoma on presentation or other concomitant disease including hepatitis C, autoimmune hepatitis, alcoholic liver disease were excluded
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method negative HBV DNA PCR ;HBeAg loss or seroconversion
- Secondary Outcome Measures
Name Time Method HBsAg level